This study tests a new preservative-free eye drop combination (QLS-111-FDC) to lower eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 adults with mild to moderate disease will receive the treatment. The goal is to see if it safely reduces eye press…
Phase: PHASE2, PHASE3 • Sponsor: Qlaris Bio, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC